XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 20, 2024, 4:00 PM
1.060
-0.030 (-2.75%)
After-hours: Dec 20, 2024, 4:03 PM EST
XORTX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 2.3 | 3.45 | 10.43 | 14.87 | 0.17 | 0.06 | Upgrade
|
Cash & Short-Term Investments | 2.3 | 3.45 | 10.43 | 14.87 | 0.17 | 0.06 | Upgrade
|
Cash Growth | -54.61% | -66.96% | -29.83% | 8582.07% | 192.20% | -77.46% | Upgrade
|
Other Receivables | 0.01 | 0.06 | 0.08 | 0.04 | 0.01 | 0.01 | Upgrade
|
Receivables | 0.01 | 0.06 | 0.08 | 0.04 | 0.01 | 0.01 | Upgrade
|
Prepaid Expenses | 0.1 | 0.24 | 0.38 | 0.44 | 0.26 | 0.01 | Upgrade
|
Other Current Assets | - | 0.32 | - | 0.56 | 1.61 | 0.74 | Upgrade
|
Total Current Assets | 2.41 | 4.07 | 10.9 | 15.91 | 2.06 | 0.82 | Upgrade
|
Property, Plant & Equipment | 0.05 | 0.02 | 0.09 | - | - | 0 | Upgrade
|
Other Intangible Assets | 0.19 | 0.18 | 0.2 | 0.2 | 0.23 | 0.27 | Upgrade
|
Other Long-Term Assets | 1.2 | 1.2 | 1.19 | 1.27 | - | - | Upgrade
|
Total Assets | 3.85 | 5.47 | 12.37 | 17.38 | 2.29 | 1.09 | Upgrade
|
Accounts Payable | 0.11 | 0.2 | 1.29 | 0.32 | 0.39 | 0.61 | Upgrade
|
Accrued Expenses | 0.22 | 0.09 | 0.15 | 0.23 | 0.64 | 0.54 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 0.05 | Upgrade
|
Current Portion of Leases | 0.06 | 0.01 | 0.07 | - | - | - | Upgrade
|
Other Current Liabilities | - | - | - | - | - | 0.1 | Upgrade
|
Total Current Liabilities | 0.39 | 0.29 | 1.51 | 0.55 | 1.03 | 1.3 | Upgrade
|
Long-Term Leases | - | - | 0.01 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 1.33 | 0.53 | 3.85 | 3.63 | - | - | Upgrade
|
Total Liabilities | 1.72 | 0.83 | 5.38 | 4.18 | 1.03 | 1.3 | Upgrade
|
Common Stock | 17.87 | 17.06 | 16.52 | 16.09 | 8.26 | 5.86 | Upgrade
|
Retained Earnings | -21.29 | -17.85 | -15.7 | -7.98 | -8.04 | -6.76 | Upgrade
|
Comprehensive Income & Other | 5.55 | 5.44 | 6.17 | 5.09 | 1.04 | 0.68 | Upgrade
|
Shareholders' Equity | 2.13 | 4.64 | 7 | 13.2 | 1.26 | -0.21 | Upgrade
|
Total Liabilities & Equity | 3.85 | 5.47 | 12.37 | 17.38 | 2.29 | 1.09 | Upgrade
|
Total Debt | 0.06 | 0.01 | 0.08 | - | - | 0.05 | Upgrade
|
Net Cash (Debt) | 2.24 | 3.44 | 10.36 | 14.87 | 0.17 | 0.01 | Upgrade
|
Net Cash Growth | -55.58% | -66.82% | -30.35% | 8582.07% | 2095.50% | -96.40% | Upgrade
|
Net Cash Per Share | 0.87 | 1.73 | 7.00 | 13.59 | 0.23 | 0.01 | Upgrade
|
Filing Date Shares Outstanding | 3.22 | 2.9 | 2 | 1.44 | 1.04 | 0.77 | Upgrade
|
Total Common Shares Outstanding | 2.9 | 2 | 1.67 | 1.44 | 0.77 | 0.6 | Upgrade
|
Working Capital | 2.02 | 3.77 | 9.38 | 15.36 | 1.02 | -0.48 | Upgrade
|
Book Value Per Share | 0.73 | 2.32 | 4.19 | 9.15 | 1.64 | -0.36 | Upgrade
|
Tangible Book Value | 1.95 | 4.47 | 6.8 | 13 | 1.02 | -0.48 | Upgrade
|
Tangible Book Value Per Share | 0.67 | 2.23 | 4.07 | 9.01 | 1.33 | -0.81 | Upgrade
|
Machinery | 0.02 | 0.02 | 0.02 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.